Genetic relationships between the gut microbiota and prostate cancer: Mendelian randomization combined with bioinformatics analysis

Comprehensive Summary

Li et al present a study investigating whether specific gut microbiota have a causal relationship with the development of prostate cancer and identifies potential underlying genetic mechanisms of this. The authors conducted a Mendelian randomization analysis using GWAS data on gut microbiota and prostate cancer, followed by colocalization and gene expression analyses. Machine learning models were then applied to identify key genes and build a predictive model. Sixteen gut bacterial taxa were identified as either increasing or decreasing prostate cancer risk. Eighteen associated genes were differentially expressed and enriched in Wnt and Hippo signaling pathways. Five key genes showed strong predictive value for prostate cancer. The results suggest gut microbiota may affect prostate cancer through tumor growth and invasion pathways. Further experimental studies are needed to validate these findings.

Outcomes and Implications

The medical implications of this study lie in the fact that it provides genetic evidence supporting a causal link between gut microbiota and prostate cancer, helping clarify mechanisms that were previously based largely on association studies. Clinically, the findings suggest that specific microbial taxa and related genes could serve as future biomarkers for prostate cancer risk assessment or as targets for microbiome-based interventions. While the results show strong potential relevance, the authors note that clinical application is not imminent and will require further experimental validation and prospective studies before implementation in medical practice.